Zamerovimab Usage And Synthesis

Uses

Zamerovimab (CTB011) is an anti-rabies humanized IgG1κ monoclonal antibody that binds to the non-overlapping epitopes on the rabies virus (RABV) glycoprotein. Zamerovimab targets residues at and near antigenic site III. Zamerovimab can be used in rabies studies[1].

References

[1] Tzu-Yuan Chao, et al. SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies. PLoS Negl Trop Dis. 2017 Dec 20;11(12):e0006133. DOI:10.1371/journal.pntd.0006133

Zamerovimab(2419087-87-7)Related Product Information

• Duvortuxizumab
• Dafsolimab
• Dostarlimab
• Sirtratumab
• Immunoglobulin G1,anti-(human NCA-90 granulocyte cell antigen) (mouse monoclonal IMMU-MN3 g1-chain), disulfide with mousemonoclonal IMMU-MN3 k-chain, dimer (9CI)
• Osocimab
• Anumigilimab
• Tuvonralimab
• Ulenistamab
• Suvratoxumab